Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Biogen
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of clinically-definite relapsing-remitting multiple sclerosis
You may not be if
Any Product Information-specified contraindications to interferon-beta therapy, or other medical factors which, in the opinion of the investigator, make the subject unsuitable for interferon-beta therapy
Use of AVONEX, but not other interferon therapies, in the 3 months prior to randomisation into the study
A clinically significant infectious illness (e.g., cellulitis, abscess, pneumonia, septicemia) within 30 days prior to randomisation.
History of seizure in the 3 months prior to randomisation
History of suicidal ideation or severe depression within the 3 months prior to randomisation.
